Your browser doesn't support javascript.
loading
Durability of neutralizing antibodies against yellow fever virus after vaccination in healthy adults.
De Santis, Riccardo; Faggioni, Giovanni; Amoroso, Alessandra; Ciammaruconi, Andrea; Pomponi, Alice; Stella Lia, Maria; Amatore, Donatella; Molinari, Filippo; Petralito, Giancarlo; Stefanelli, Paola; Rezza, Giovanni; Lista, Florigio.
Afiliação
  • De Santis R; Scientific Department, Army Medical Center, Rome, Italy.
  • Faggioni G; Scientific Department, Army Medical Center, Rome, Italy. Electronic address: giovanni.faggioni@gmail.com.
  • Amoroso A; Scientific Department, Army Medical Center, Rome, Italy.
  • Ciammaruconi A; Scientific Department, Army Medical Center, Rome, Italy.
  • Pomponi A; Scientific Department, Army Medical Center, Rome, Italy.
  • Stella Lia M; Scientific Department, Army Medical Center, Rome, Italy.
  • Amatore D; Scientific Department, Army Medical Center, Rome, Italy.
  • Molinari F; Scientific Department, Army Medical Center, Rome, Italy.
  • Petralito G; Scientific Department, Army Medical Center, Rome, Italy.
  • Stefanelli P; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Rezza G; Health Prevention Directorate, Ministry of Health, Rome, Italy.
  • Lista F; Scientific Department, Army Medical Center, Rome, Italy.
Vaccine ; 41(17): 2761-2763, 2023 04 24.
Article em En | MEDLINE | ID: mdl-36967285
ABSTRACT
In accordance with the World Health Organization, one dose of yellow fever vaccine may guarantee protection lifelong in healthy adults. However, relatively little information is still available from ad hoc studies. We evaluated the persistence of neutralizing antibodies, which are considered to be an immune correlate of protection, in a large number of military personnel vaccinated up to 47 years before. Overall, 322 individuals were studied. The median time from vaccination to blood collection for neutralizing antibody evaluation was 9 years, ranging from <1 to 47 years. Of the 322 participants, 319 had neutralizing antibodies (99.1 %). The highest median PRNT50 value was observed in those vaccinated ≤1 year before (median PRNT50 = 320). In conclusion, our study confirms on a larger scale that, in healthy adults, neutralizing antibodies may persist as long as 47 years after a single yellow fever vaccines dose.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacina contra Febre Amarela Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacina contra Febre Amarela Idioma: En Ano de publicação: 2023 Tipo de documento: Article